相关实验视频

Updated: May 5, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

基于凝的平台用于癌症治疗中特定部位的多克索鲁比辛释放

Chunbao Zang¹, Yu Tian^2,3, Yujing Tang⁴

¹Department of Radiation Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, 230031, China.

Journal of translational medicine

|October 1, 2024

概括

水凝为多克索鲁比 (DOX) 等化疗药物提供了先进的输送,增强了抗癌活性并克服了耐药性. 这些生物相容系统提高了治疗效率,并减少了癌症治疗中的副作用.

科学领域:

生物材料科学生物材料科学
癌症治疗方法癌症治疗方法
药物输送系统药物输送系统

背景情况:

水凝是具有可调节性质的生物相容材料,因此非常适合用于药物输送.
多克索鲁比 (DOX) 是一种常见的化疗药物,但瘤耐药性限制了其有效性.
需要新的输送系统来增强DOX内部化和抗癌活性.

研究的目的:

审查在癌症治疗中用于增强多克索鲁比 (DOX) 输送的水凝的使用.
探索水凝如何克服DOX耐药性并改善治疗结果.
为了突出基于水凝的DOX输送系统的进步.

主要方法:

对用于DOX输送的天然基水凝 (酸盐,酸盐,凝) 的审查.
研究水凝策略,包括纳米粒子结合和刺激响应系统 (pH,氧化还原,热).
对与其他药物联合输送DOX的水凝进行分析.

主要成果:

水凝提供持续的DOX释放,增加细胞毒性和减少副作用.
天然水凝显示出良好的生物相容性和可降解性,用于瘤抑制.
纳米粒子载荷和刺激响应的水凝增强了DOX内部化和有针对性的释放.
联合交付策略协同抑制癌症的进展.

结论:

水凝是改善癌症治疗中多克索鲁比 (DOX) 输送的有效平台.
先进的水凝设计,包括刺激响应和纳米粒子集成系统,为临床应用提供了显著的潜力.
基于水凝的DOX输送可以克服耐药性并提高整体化疗的疗效.

关键词:

癌症治疗治疗癌症治疗化疗化疗是一种化学疗法.德克索鲁比辛是一种多克索鲁比辛.药物输送是药物输送的过程.水凝是一种水凝.

更多相关视频

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

相关概念视频

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...